Open Access<p>Chemotherapy of Locally Advanced or Metastatic Urothelial Cell Carcinoma: Monocentric Real-Life Data</p>
Author(s) -
Christine Fischer,
Rainer Hofmann,
Axel Hegele
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s231508
Subject(s) - medicine , gemcitabine , chemotherapy , oncology , metastatic urothelial carcinoma , cisplatin , urology , urothelial carcinoma , bladder cancer , cancer
Up to 30% of all patients will present with an advanced or a metastatic stage (mUCC) at the moment of the initial diagnosis of urothelial cell carcinoma of the bladder (UCC). We investigated the numbers, the efficacy and toxicity of different chemotherapies for mUCC in daily practice and "real-life" conditions and evaluated them substance-specifically.